Amplia Therapeutics Limited Share Price OTC Markets
Stocks
INNMF
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1150 USD | +43.75% |
|
-.--% | +45.75% |
| Market Cap | 6.93Cr 4.79Cr 4.2Cr 3.88Cr 3.58Cr 6.79Cr 458.65Cr 47Cr 18Cr 224.45Cr 18Cr 18Cr 779.15Cr | P/E 2027 * |
-6.09x | P/E 2028 * | -23.3x |
|---|---|---|---|---|---|
| Enterprise Value | 5.38Cr 3.72Cr 3.26Cr 3.01Cr 2.78Cr 5.27Cr 356.06Cr 36Cr 14Cr 174.24Cr 14Cr 14Cr 604.87Cr | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 4.78x |
| Free-Float |
84.81% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 day | +43.75% | ||
| 1 month | +15.00% | ||
| 3 months | -17.86% | ||
| 6 months | -4.17% | ||
| Current year | +45.75% |
| 1 month | 0.08 |  | 0.12 |
| Current year | 0.06 | | 0.27 |
| 1 year | 0.05 | | 0.27 |
| 3 years | 0.02 | | 0.27 |
| 5 years | 0.02 | | 0.27 |
| 10 years | 0.01 | | 1.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 05/12/2022 | |
Hamish George
DFI | Director of Finance/CFO | - | 01/10/2021 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 02/09/2015 |
Warwick Tong
CHM | Chairman | - | 25/05/2018 |
Jane Bell
CHM | Chairman | - | 30/06/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +43.75% | -.--% | - | - | 4.97Cr | |
| +1.03% | -2.21% | +73.55% | +129.52% | 5.67TCr | |
| -2.45% | -7.83% | +63.92% | +83.15% | 5.13TCr | |
| +0.01% | +5.09% | +21.58% | +474.93% | 2.53TCr | |
| +1.10% | -3.40% | -15.70% | -12.29% | 2.37TCr | |
| +3.93% | +3.35% | +43.09% | -2.47% | 1.87TCr | |
| +1.77% | +2.19% | +39.63% | -25.05% | 1.77TCr | |
| +2.34% | +12.50% | +224.02% | +380.99% | 1.77TCr | |
| -0.92% | +1.58% | +35.79% | - | 1.43TCr | |
| +1.07% | +0.85% | +27.81% | +195.36% | 1.41TCr | |
| Average | +5.11% | +4.02% | +57.08% | +153.02% | 2.66TCr | |
| Weighted average by Cap. | +0.39% | +2.20% | +58.48% | +143.59% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 1Cr 69.12L 60.63L 55.97L 51.72L 98.04L 66Cr 6.73Cr 2.61Cr 32Cr 2.6Cr 2.54Cr 112.44Cr |
| Net income | -1.16Cr -80.18L -70.33L -64.93L -60L -1.14Cr -77Cr -7.81Cr -3.03Cr -38Cr -3.01Cr -2.95Cr -130.43Cr | -36L -24.88L -21.83L -20.15L -18.62L -35.29L -24Cr -2.42Cr -94.12L -12Cr -93.45L -91.4L -40Cr |
| Net Debt | -1.55Cr -1.07Cr -93.97L -86.76L -80.17L -1.52Cr -102.59Cr -10Cr -4.05Cr -50Cr -4.02Cr -3.94Cr -174.28Cr | -2.15Cr -1.49Cr -1.3Cr -1.2Cr -1.11Cr -2.11Cr -142.3Cr -14Cr -5.62Cr -70Cr -5.58Cr -5.46Cr -241.74Cr |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $0.1150 | +43.75% | 37,250 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1400AUD
Average target price
0.4200AUD
Spread / Average Target
+200.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
- INNMF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
